Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Obeticholic acid for non-alcoholic steatohepatitis and fibrosis Obeticholic Acid (Ocaliva; INT-747) Non-alcoholic steatohepatitis (NASH) Hepatology 2019 View  |  Download
Ofatumumab for relapsing multiple sclerosis Ofatumumab (Arzerra) Multiple sclerosis (MS) Neurology 2019 View  |  Download
Olaparib for BRCAm or ATM mutated metastatic castration-resistant prostate cancer Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Prostate cancer Male Reproductive Cancer 2019 View  |  Download
Olaparib in combination with bevacizumab for ovarian, fallopian tube or primary peritoneal cancer – maintenance therapy Bevacizumab (Avastin; R 435; RG 405; RG 435) , Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Fallopian tube cancer , Ovarian cancer , primary peritoneal cancer Female Reproductive Cancer 2019 View  |  Download
Olaparib monotherapy for BRCA-mutated platinum-sensitive relapsed ovarian, fallopian tube or primary peritoneal cancer Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2019 View  |  Download
Omalizumab for chronic rhinosinusitis with nasal polyps Omalizumab (Xolair) Rhinosinusitis Ear Nose and Throat (ENT) 2019 View  |  Download
Onfekafusp alfa in addition to doxorubicin for advanced or metastatic soft tissue sarcoma – first line Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Onfekafusp alfa (L19-TNF; Fibromun) Soft tissue sarcoma Sarcoma 2019 View  |  Download
OTL-200 for Metachromatic Leukodystrophy OTL-200 (GSK-2696274) Metachromatic leukodystrophy (MLD) Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2019 View  |  Download
Palovarotene for episodic and chronic use in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
Palovarotene for flare-ups in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
1 2 8 9 10 11 12 14 15
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications